• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表观转录组学与宫颈癌:m~A、m~C 和 m~A RNA 修饰的新兴作用。

Epitranscriptomics and cervical cancer: the emerging role of mA, mC and mA RNA modifications.

机构信息

Department of Biological Sciences, University of Toronto, Scarborough, Canada.

Department of Biology, University of Toronto, Mississauga, Canada.

出版信息

Expert Rev Mol Med. 2024 Oct 8;26:e20. doi: 10.1017/erm.2024.20.

DOI:10.1017/erm.2024.20
PMID:39377535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11488341/
Abstract

Cervical cancer (CC), one of the most prevalent and detrimental gynaecologic cancers, evolves through genetic and epigenetic alterations resulting in the promotion of oncogenic activity and dysfunction of tumour-suppressing mechanisms. Despite medical advancement, the prognosis for advanced-stage patients remains extremely low due to high recurrence rates and resistance to existing treatments. Thereby, the search for potential prognostic biomarkers is heightened to unravel new modalities of CC pathogenesis and to develop novel anti-cancer therapies. Epitranscriptomic modifications, reversible epigenetic RNA modifications, regulate various biological processes by deciding RNA fate to mediating RNA interactions. This narrative review provides insight into the cellular and molecular roles of endogenous RNA-editing proteins and their associated epitranscriptomic modifications, especially -methyladenosine (mA), 5-methylcytosine (mC) and -methyladenosine (mA), in governing the development, progression and metastasis of CC. We discussed the in-depth epitranscriptomic mechanisms underlying the regulation of over 50 RNAs responsible for tumorigenesis, proliferation, migration, invasion, survival, autophagy, stemness, epithelial-mesenchymal transition, metabolism (glucose, lipid, glutamate and glutamine), resistance (drug and radiation), angiogenesis and recurrence of CC. Additionally, we provided a concise overview of the therapeutic potential of targeting the altered expression of endogenous RNA-editing proteins and aberrant deposition of RNA modifications on both coding and non-coding RNAs in CC.

摘要

宫颈癌 (CC) 是最常见和危害最大的妇科癌症之一,其发生是由于遗传和表观遗传改变导致致癌活性的促进和肿瘤抑制机制的功能障碍。尽管医学取得了进步,但由于高复发率和对现有治疗方法的耐药性,晚期患者的预后仍然极低。因此,寻找潜在的预后生物标志物的需求增加,以揭示 CC 发病机制的新方式,并开发新的抗癌疗法。

表观转录组修饰是可逆的 RNA 表观遗传修饰,通过决定 RNA 命运来调节 RNA 相互作用,从而调节各种生物学过程。本综述深入探讨了内源性 RNA 编辑蛋白及其相关表观转录组修饰(特别是 mA、mC 和 mA)在调节 CC 发生、发展和转移中的细胞和分子作用。我们讨论了 50 多种负责肿瘤发生、增殖、迁移、侵袭、存活、自噬、干性、上皮-间充质转化、代谢(葡萄糖、脂质、谷氨酸和谷氨酰胺)、耐药性(药物和辐射)、血管生成和 CC 复发的 RNA 调节的深入表观转录组机制。此外,我们还简要概述了靶向内源性 RNA 编辑蛋白表达改变和 RNA 修饰在编码和非编码 RNA 上的异常沉积在 CC 中的治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be3e/11488341/9314785fa478/S1462399424000206_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be3e/11488341/5493e99e412d/S1462399424000206_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be3e/11488341/4c29816e2f35/S1462399424000206_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be3e/11488341/3e4dc544a208/S1462399424000206_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be3e/11488341/9314785fa478/S1462399424000206_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be3e/11488341/5493e99e412d/S1462399424000206_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be3e/11488341/4c29816e2f35/S1462399424000206_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be3e/11488341/3e4dc544a208/S1462399424000206_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be3e/11488341/9314785fa478/S1462399424000206_fig4.jpg

相似文献

1
Epitranscriptomics and cervical cancer: the emerging role of mA, mC and mA RNA modifications.表观转录组学与宫颈癌:m~A、m~C 和 m~A RNA 修饰的新兴作用。
Expert Rev Mol Med. 2024 Oct 8;26:e20. doi: 10.1017/erm.2024.20.
2
Deciphering the Epitranscriptomic Signatures in Cell Fate Determination and Development.解析细胞命运决定和发育中的表观转录组特征。
Stem Cell Rev Rep. 2019 Aug;15(4):474-496. doi: 10.1007/s12015-019-09894-3.
3
Integrated analysis of N6-methyladenosine- and 5-methylcytosine-related long non-coding RNAs for predicting prognosis in cervical cancer.N6-甲基腺苷和 5-甲基胞嘧啶相关长非编码 RNA 的综合分析用于预测宫颈癌的预后。
Hereditas. 2024 Sep 16;161(1):34. doi: 10.1186/s41065-024-00336-w.
4
RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.RNA 修饰与表观遗传学在调控肺癌及肺部疾病中的作用。
Int J Mol Sci. 2021 Sep 30;22(19):10592. doi: 10.3390/ijms221910592.
5
Writers, readers, and erasers RNA modifications and drug resistance in cancer.RNA 修饰与癌症的药物耐药性:作者、读者和橡皮擦
Mol Cancer. 2024 Aug 30;23(1):178. doi: 10.1186/s12943-024-02089-6.
6
The role of mA, mC and Ψ RNA modifications in cancer: Novel therapeutic opportunities.mA、mC 和 Ψ RNA 修饰在癌症中的作用:新的治疗机会。
Mol Cancer. 2021 Jan 18;20(1):18. doi: 10.1186/s12943-020-01263-w.
7
m6A modification of RNA in cervical cancer: role and clinical perspectives.RNA 在宫颈癌中的 m6A 修饰:作用与临床展望。
RNA Biol. 2024 Jan;21(1):49-61. doi: 10.1080/15476286.2024.2408707. Epub 2024 Sep 30.
8
Epitranscriptomic Regulations in the Heart.心脏中的转录后调控
Physiol Res. 2024 Apr 18;73(Suppl 1):S185-S198. doi: 10.33549/physiolres.935265.
9
NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer.NSUN6 介导的 NDRG1 mRNA 5-甲基胞嘧啶修饰促进宫颈癌的放射抵抗。
Mol Cancer. 2024 Jul 5;23(1):139. doi: 10.1186/s12943-024-02055-2.
10
Novel insight into the regulatory roles of diverse RNA modifications: Re-defining the bridge between transcription and translation.深入了解多种 RNA 修饰的调控作用:重新定义转录和翻译之间的桥梁。
Mol Cancer. 2020 Apr 17;19(1):78. doi: 10.1186/s12943-020-01194-6.

引用本文的文献

1
Epitranscriptomic mechanisms and implications of RNA mC modification in cancer.癌症中RNA mC修饰的表观转录组学机制及其影响
Theranostics. 2025 Jul 25;15(16):8404-8428. doi: 10.7150/thno.112332. eCollection 2025.
2
Quantifying the mRNA epitranscriptome reveals epitranscriptome signatures and roles in cancer.对信使核糖核酸表观转录组进行定量分析揭示了表观转录组特征及其在癌症中的作用。
Cell Mol Life Sci. 2025 Jul 28;82(1):290. doi: 10.1007/s00018-025-05805-7.
3
Integrative analysis of m6A-SNPs and single-cell RNA sequencing reveals key drivers of endocrine combined with CDK4/6 inhibitor therapy resistance in ER+ breast cancer.

本文引用的文献

1
RBM15 Knockdown Impairs the Malignancy of Cervical Cancer by Mediating m6A Modification of Decorin.RBM15基因敲低通过介导核心蛋白聚糖的m6A修饰来损害宫颈癌的恶性程度。
Biochem Genet. 2025 Feb;63(1):225-238. doi: 10.1007/s10528-024-10757-x. Epub 2024 Mar 1.
2
M6A modification regulates tumor suppressor DIRAS1 expression in cervical cancer cells.M6A 修饰调控宫颈癌细胞中肿瘤抑制因子 DIRAS1 的表达。
Cancer Biol Ther. 2024 Dec 31;25(1):2306674. doi: 10.1080/15384047.2024.2306674. Epub 2024 Feb 19.
3
IGF2BP3 enhances lipid metabolism in cervical cancer by upregulating the expression of SCD.
m6A单核苷酸多态性与单细胞RNA测序的综合分析揭示了雌激素受体阳性乳腺癌中内分泌联合CDK4/6抑制剂治疗耐药的关键驱动因素。
Front Pharmacol. 2025 Apr 15;16:1590363. doi: 10.3389/fphar.2025.1590363. eCollection 2025.
4
5-Methylcytosine methylation predicts cervical cancer prognosis, shaping immune cell infiltration.5-甲基胞嘧啶甲基化可预测宫颈癌预后,影响免疫细胞浸润。
J Int Med Res. 2025 Apr;53(4):3000605251328301. doi: 10.1177/03000605251328301. Epub 2025 Apr 12.
IGF2BP3通过上调SCD的表达增强宫颈癌中的脂质代谢。
Cell Death Dis. 2024 Feb 14;15(2):138. doi: 10.1038/s41419-024-06520-0.
4
Transcriptome sequencing analysis reveals miR-30c-5p promotes ferroptosis in cervical cancer and inhibits growth and metastasis of cervical cancer xenografts by targeting the METTL3/KRAS axis.转录组测序分析表明,miR-30c-5p通过靶向METTL3/KRAS轴促进宫颈癌的铁死亡,并抑制宫颈癌异种移植瘤的生长和转移。
Cell Signal. 2024 May;117:111068. doi: 10.1016/j.cellsig.2024.111068. Epub 2024 Jan 27.
5
The m6A methyltransferase RBM15 affects tumor cell stemness and progression of cervical cancer by regulating the stability of lncRNA HEIH.m6A 甲基转移酶 RBM15 通过调节长链非编码 RNA HEIH 的稳定性影响宫颈癌肿瘤细胞干性和进展。
Exp Cell Res. 2024 Mar 15;436(2):113924. doi: 10.1016/j.yexcr.2024.113924. Epub 2024 Jan 26.
6
METTL3-mediated HSPA9 m6A modification promotes malignant transformation and inhibits cellular senescence by regulating exosomal mortalin protein in cervical cancer.METTL3 介导的 HSPA9 m6A 修饰通过调节宫颈癌细胞外泌体 mortalin 蛋白促进恶性转化和抑制细胞衰老。
Cancer Lett. 2024 Apr 10;587:216658. doi: 10.1016/j.canlet.2024.216658. Epub 2024 Jan 20.
7
The inhibition of YTHDF3/mA/LRP6 reprograms fatty acid metabolism and suppresses lymph node metastasis in cervical cancer.YTHDF3/mA/LRP6 抑制作用重塑脂肪酸代谢并抑制宫颈癌淋巴结转移。
Int J Biol Sci. 2024 Jan 12;20(3):916-936. doi: 10.7150/ijbs.87203. eCollection 2024.
8
Glycolysis Induced by METTL14 Is Essential for Macrophage Phagocytosis and Phenotype in Cervical Cancer.METTL14 诱导的糖酵解对宫颈癌中巨噬细胞的吞噬作用和表型至关重要。
J Immunol. 2024 Feb 15;212(4):723-736. doi: 10.4049/jimmunol.2300339.
9
LRRC75A-AS1 Drives the Epithelial-Mesenchymal Transition in Cervical Cancer by Binding IGF2BP1 and Inhibiting SYVN1-Mediated NLRP3 Ubiquitination.LRRC75A-AS1通过结合IGF2BP1并抑制SYVN1介导的NLRP3泛素化驱动宫颈癌的上皮-间质转化。
Mol Cancer Res. 2024 Dec 3;22(12):1075-1087. doi: 10.1158/1541-7786.MCR-23-0478.
10
IGF2BP3-mediated regulation of and gene expression promotes treg-induced immune escape in human cervical cancer.IGF2BP3介导的 和 基因表达调控促进人宫颈癌中调节性T细胞诱导的免疫逃逸。 (注:原文中“和”前面的部分缺失,你可补充完整后再让我准确翻译)
Am J Cancer Res. 2023 Nov 15;13(11):5289-5305. eCollection 2023.